$238 Million is the total value of Stonepine Capital Management, LLC's 19 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 63.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AMYT | Buy | AMRYT PHARMA PLC - SPNR ADRsponsored ads | $46,232,645 | +7.3% | 6,333,239 | +1.7% | 19.45% | +0.4% |
| APEN | Buy | APOLLO ENDOSURGERY INC | $37,154,042 | +138.0% | 3,726,584 | +31.6% | 15.63% | +122.7% |
| CTIC | Sell | CTI BIOPHARMA CORP | $29,653,941 | -10.1% | 4,934,100 | -13.0% | 12.48% | -15.9% |
| ADMA | Buy | ADMA BIOLOGICS INC | $26,927,200 | +121.6% | 6,940,000 | +38.8% | 11.33% | +107.4% |
| Sell | QUIDELORTHO CORP | $25,701,000 | -28.3% | 300,000 | -40.2% | 10.81% | -32.9% | |
| Sell | XERIS BIOPHARMA HOLDINGS INC | $14,889,601 | -26.2% | 11,195,189 | -13.4% | 6.26% | -30.9% | |
| URGN | Buy | UROGEN PHARMA LTD | $11,574,880 | +23.7% | 1,304,947 | +16.1% | 4.87% | +15.8% |
| New | THIRD HARMONIC BIO INC | $8,665,794 | – | 2,015,301 | +100.0% | 3.65% | – | |
| GLPG | New | GALAPAGOS NV-SPON ADRspon adr | $8,646,822 | – | 194,836 | +100.0% | 3.64% | – |
| EOLS | Buy | EVOLUS INC | $6,266,584 | +289.2% | 834,432 | +317.2% | 2.64% | +264.1% |
| RZLT | Buy | REZOLUTE INC | $6,254,513 | -23.2% | 3,021,504 | +1.6% | 2.63% | -28.2% |
| CSTL | New | CASTLE BIOSCIENCES INC | $4,195,770 | – | 178,240 | +100.0% | 1.76% | – |
| CFMS | Sell | CONFORMIS INC | $2,484,004 | -24.9% | 748,194 | -95.7% | 1.04% | -29.8% |
| MIRM | New | MIRUM PHARMACEUTICALS INC | $2,120,996 | – | 108,769 | +100.0% | 0.89% | – |
| XGN | Sell | EXAGEN INC | $2,049,701 | -40.2% | 854,042 | -32.5% | 0.86% | -44.1% |
| New | MAXCYTE INC | $1,492,147 | – | 273,287 | +100.0% | 0.63% | – | |
| New | OMNIAB INC | $1,275,358 | – | 354,266 | +100.0% | 0.54% | – | |
| XOMA | XOMA CORP | $1,186,046 | +2.8% | 64,459 | 0.0% | 0.50% | -3.9% | |
| OPTN | Sell | OPTINOSE INC | $940,325 | -87.2% | 508,284 | -74.6% | 0.40% | -88.0% |
| OPNT | Exit | OPIANT PHARMACEUTICALS INC | $0 | – | -152,278 | -100.0% | -0.74% | – |
| LIFE | Exit | ATYR PHARMA INC | $0 | – | -600,980 | -100.0% | -0.81% | – |
| OVID | Exit | OVID THERAPEUTICS INC | $0 | – | -1,540,671 | -100.0% | -1.27% | – |
| AFMD | Exit | AFFIMED NV | $0 | – | -1,979,828 | -100.0% | -1.83% | – |
| LGND | Exit | LIGAND PHARMACEUTICALS | $0 | – | -99,562 | -100.0% | -3.85% | – |
| AMRN | Exit | AMARIN CORP PLC -ADRspons adr new | $0 | – | -8,547,965 | -100.0% | -4.19% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CTI Biopharmap Corp. | 24 | Q1 2023 | 14.8% |
| APOLLO ENDOSURGERY INC | 23 | Q1 2023 | 15.6% |
| XOMA CORP | 20 | Q3 2023 | 5.7% |
| Cumberland Pharmaceuticals, Inc. | 19 | Q4 2020 | 7.0% |
| Amarin Corp PLC - SPONS ADR | 14 | Q3 2022 | 23.2% |
| VANDA PHARMACEUTICALS INC | 14 | Q3 2023 | 20.9% |
| BIODELIVERY SCIENCES INTL | 14 | Q1 2020 | 12.9% |
| AFFIMED NV | 13 | Q3 2022 | 7.7% |
| ALIMERA SCIENCES INC | 13 | Q3 2019 | 4.2% |
| VIVEVE MEDICAL INC | 12 | Q2 2019 | 15.3% |
View Stonepine Capital Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| CTI BIOPHARMA CORP | April 13, 2023 | 7,018,046 | 5.3% |
| ADMA BIOLOGICS, INC. | February 13, 2023 | 6,940,000 | 3.1% |
| Amryt Pharma plc | February 13, 2023 | 31,666,195 | 9.9% |
| Apollo Endosurgery, Inc. | February 13, 2023 | 4,351,088 | 9.0% |
| Conformis Inc | February 13, 2023 | 748,194 | 9.9% |
| Ovid Therapeutics Inc.Sold out | February 13, 2023 | 0 | 0.0% |
| Adamas Pharmaceuticals IncSold out | February 14, 2022 | 0 | 0.0% |
| CATALYST BIOSCIENCES, INC.Sold out | February 14, 2022 | 0 | 0.0% |
| Conformis Inc | February 14, 2022 | 14,768,823 | 7.9% |
| YUMANITY THERAPEUTICS, INC.Sold out | February 14, 2022 | 0 | 0.0% |
View Stonepine Capital Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-04-19 |
| 13F-HR | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
View Stonepine Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.